CompletedNot Applicable

Bedside Monitoring to Identify Impaired Cerebral Autoregulation in Women with Postpartum Hypertension

United States5 participantsStarted 2021-08-13

Plain-language summary

The purpose of this research study is to develop a protocol for NIRS-based bedside monitoring to identify impaired cerebral autoregulation in women admitted to the high-risk obstetrics unit with postpartum hypertension. The investigators will then pilot this protocol in 10 patients with high-risk neurological features, such as headache.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Women who have given birth within the previous 12 weeks * Admitted to the high-risk inpatient obstetrics unit for management of hypertension * With headache or other neurological symptoms such as vision changes Exclusion Criteria: * Acute ischemic stroke * Intracerebral or subarachnoid hemorrhage * Eclamptic seizures * Any other neurological complication requiring transfer to the neurological intensive care unit or stroke stepdown unit * History of Reynaud's syndrome

What they're measuring

Oxygenated hemoglobin concentration

Timeframe: Continuously collected for up to 24 hours

Deoxygenated hemoglobin concentration

Timeframe: Continuously collected for up to 24 hours

Blood pressure (BP)

Timeframe: Continuously collected for up to 24 hours

Trial details

NCT IDNCT05155852

SponsorColumbia University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-03-13

View on ClinicalTrials.gov More Preeclampsia trials